Orbital Cellulitis
Etiology, Clinical Features, Management & Complications
Examination question · ~800 words
Define orbital cellulitis. Discuss its etiology, clinical features, investigations, management, complications, and differentiation from preseptal cellulitis.
Try to outline your answer mentally before expanding sections below.
Orbital cellulitis is an acute infection of the soft tissues posterior to the orbital septum. It is a true ophthalmic and medical emergency because delayed treatment may cause irreversible visual loss, cavernous sinus thrombosis, meningitis, intracranial abscess, septic shock, or death. It must be distinguished from preseptal cellulitis, which is confined anterior to the orbital septum and has a much better prognosis.
The orbital septum is a fibrous membrane arising from the periosteum of the orbital rim at the arcus marginalis. Superiorly it inserts into the levator aponeurosis, and inferiorly it inserts into the tarsal plate. It forms the key anatomical barrier separating preseptal from postseptal infection.
| Space | Anatomy | Clinical Entity |
|---|---|---|
| Preseptal / periorbital space | Skin and subcutaneous tissue anterior to the orbital septum | Preseptal cellulitis |
| Postseptal / orbital space | Orbital fat, extraocular muscles, optic nerve and vessels posterior to the septum | Orbital cellulitis |
The septum is the key boundary: infection anterior to it is preseptal cellulitis; infection posterior to it is orbital cellulitis.
Once the septum is breached by sinus spread, trauma, surgery, or penetrating injury, infection can enter the orbit and threaten vision or life.
Chandler's classification stages orbital complications of sinusitis from preseptal inflammation to cavernous sinus thrombosis. The original 1970 Chandler classification was based on clinical staging; modern practice applies the same staging together with CT findings for localization of abscess and surgical planning.
| Grade | Name | Features | Management |
|---|---|---|---|
| I | Inflammatory oedema / preseptal cellulitis | Lid oedema without proptosis, chemosis, RAPD, or postseptal signs | IV antibiotics or oral antibiotics depending on severity; close monitoring |
| II | Orbital cellulitis | Proptosis, chemosis, painful restricted EOM; no abscess on CT | Admit, IV antibiotics, close ophthalmic monitoring; repeat imaging if no improvement in 24-48 h |
| III | Subperiosteal abscess | Collection between periorbita and bony orbital wall, classically medial wall adjacent to ethmoid sinus | IV antibiotics plus selective surgical drainage depending on age, size, site, and visual status |
| IV | Orbital abscess | Pus within orbital fat with severe proptosis, ophthalmoplegia, toxicity, or visual threat | Urgent surgical drainage plus IV antibiotics |
| V | Cavernous sinus thrombosis | Bilateral signs, high septic fever, meningism, ophthalmoplegia, bilateral chemosis/proptosis | ICU care, broad-spectrum IV antibiotics, LMWH anticoagulation, ENT/neurosurgery input |
1. Sinusitis: Most Common Source
Paranasal sinusitis accounts for the majority of orbital cellulitis cases. The ethmoid sinus is the most common source, especially in children, because the thin lamina papyracea allows direct spread into the orbit.
| Sinus | Route / Association |
|---|---|
| Ethmoid sinus | Most common source; spread through lamina papyracea dehiscence, erosion, or valveless venous channels |
| Maxillary sinus | Spread via inferior orbital fissure or direct extension |
| Frontal sinus | May cause superior subperiosteal abscess; associated with Pott's puffy tumour |
| Sphenoid sinus | Associated with orbital apex involvement and cavernous sinus thrombosis |
2. Other Sources
- Contiguous spread from facial cellulitis, dacryocystitis, dental infection, panophthalmitis, or infected eyelid/orbital wounds.
- Post-traumatic infection, especially penetrating trauma or orbital fractures communicating with sinuses.
- Foreign body implantation, particularly wood or vegetable matter, which increases the risk of fungal infection.
- Post-operative infection after orbital, sinus, or eyelid surgery.
- Haematogenous spread during systemic sepsis, especially in neonates and immunocompromised patients.
Causative Organisms
| Group | Common Organisms | Notes |
|---|---|---|
| Children | Streptococcal species, Staphylococcus aureus, Moraxella catarrhalis; H. influenzae historically | Sinus origin common. H. influenzae type b was historically important, but is now rare in routinely Hib-vaccinated populations; non-typeable H. influenzae may still occur. |
| Adults | Polymicrobial: Staphylococcus aureus, streptococci, anaerobes, Gram-negative organisms | Dental and chronic sinus disease increase anaerobic involvement. |
| Post-trauma | Staphylococcus aureus including MRSA, Clostridium species, mixed flora | Consider MRSA in community-acquired disease and penetrating trauma. |
| Immunocompromised / diabetics | Mucorales including Rhizopus, Mucor, Absidia; Aspergillus | Rhino-orbital mucormycosis is angioinvasive and rapidly fatal without urgent treatment. |
| Neonates | Staphylococcus aureus, group B Streptococcus, Gram-negative organisms | Haematogenous spread is relatively more common. |
Preseptal vs Orbital Cellulitis
| Feature | Preseptal Cellulitis | Orbital Cellulitis |
|---|---|---|
| Proptosis | Absent | Present, axial or directional |
| Chemosis | Absent or mild | Present |
| Extraocular movements | Full and painless | Restricted and painful |
| Pain on eye movement | Absent | Characteristic |
| Visual acuity | Normal | May be reduced if optic nerve is involved |
| RAPD | Absent | Present with optic nerve compromise |
| IOP | Normal | May be raised due to proptosis and venous congestion |
| Fever/systemic toxicity | Mild or absent | Often high-grade fever and toxicity |
| CT orbit | No postseptal involvement | Postseptal fat stranding, EOM thickening, abscess, sinus disease |
Symptoms
- Painful, red, swollen eyelids; the eye may be difficult to open.
- Severe orbital ache, worsened by eye movement.
- Blurred vision, diplopia, or reduced colour vision if optic nerve function is threatened.
- Fever, malaise, headache and systemic toxicity.
- History of sinusitis, URTI, dental infection, trauma, surgery, diabetes, or immunosuppression.
Signs
- Proptosis: axial if diffuse or posterior; directional if due to a localized subperiosteal abscess, such as medial abscess causing lateral displacement.
- Chemosis with conjunctival injection and oedema.
- Restricted painful EOM, either in all directions due to inflammatory oedema or in a pattern related to abscess site.
- RAPD and reduced VA indicate optic nerve compromise and require urgent intervention.
- Raised IOP from proptosis and venous congestion.
- Lid erythema, warmth, tenderness, and tense orbital swelling.
Red flags requiring immediate senior review: reduced VA, RAPD, impaired colour vision, severe proptosis, worsening ophthalmoplegia, inability to open eyelids, optic disc changes, or bilateral signs suggesting cavernous sinus thrombosis.
1. CT Orbit and Paranasal Sinuses with Contrast
CT orbit and paranasal sinuses with contrast is the investigation of choice in suspected orbital cellulitis when orbital signs, abscess, trauma, poor response, or complications are suspected. It should include axial and coronal sections.
- Differentiates preseptal from postseptal disease.
- Shows postseptal fat stranding, extraocular muscle thickening, abscess formation, bony erosion, foreign body, and extent of sinus disease.
- Abscess appears as a hypodense collection with rim enhancement.
- Subperiosteal abscess is often a biconvex or lenticular hypodense collection, most commonly along the medial orbital wall.
- Defines anatomy and guides surgical approach.
2. MRI Orbit / Brain and MR Venography
- MRI is superior for soft tissue detail, optic nerve involvement, orbital apex disease, intracranial extension, and cavernous sinus thrombosis.
- T1 with gadolinium may show ring-enhancing abscess; T2 shows high signal in oedematous tissue.
- MRI/MRV is the gold-standard imaging approach for cavernous sinus thrombosis, showing loss of flow void and venous filling defect.
3. Blood Tests
- Full blood count: leukocytosis with neutrophilia.
- CRP and ESR: elevated and useful for response monitoring.
- Blood cultures before antibiotics, though yield is modest.
- Renal function and LFTs before IV antibiotics or antifungals.
- Blood glucose and ketones when diabetes or mucormycosis is suspected.
4. Microbiological Sampling
- Nasal swab or nasal discharge culture.
- Pus culture from abscess drainage is critical for targeted therapy.
- Lumbar puncture only when meningitis is suspected and after appropriate neuroimaging if raised ICP is a concern.
5. Ophthalmic Assessment
- Visual acuity and colour vision.
- Pupil examination for RAPD.
- Ocular motility and diplopia charting where feasible.
- IOP measurement.
- Fundoscopy for papilloedema, optic disc oedema, choroidal folds, vascular occlusion, or retinal complications.
All patients with orbital cellulitis require admission and urgent multidisciplinary care involving ophthalmology, ENT, paediatrics or medicine, microbiology, and neurosurgery when intracranial spread is suspected.
A. Initial Measures
- Admit and start IV broad-spectrum antibiotics after blood cultures if this does not delay treatment.
- Baseline and serial monitoring of VA, pupils, colour vision, EOM, proptosis, IOP, temperature, CRP, and systemic status.
- Urgent CT orbit and sinuses with contrast when orbital signs are present or abscess is suspected.
- Treat associated sinusitis with ENT input.
- Protect cornea if exposure keratopathy is present.
B. Empirical Medical Treatment
| Situation | Regimen | Notes |
|---|---|---|
| Adults, empirical first-line | IV co-amoxiclav 1.2 g TDS plus metronidazole 500 mg TDS where anaerobic cover is needed | Covers Gram-positive, Gram-negative, and anaerobic organisms; step down to oral therapy after clear improvement. |
| MRSA risk, post-trauma, severe infection, or poor response | IV vancomycin plus piperacillin-tazobactam, adjusted to local microbiology policy | Covers MRSA, Gram-negative organisms, and anaerobes. |
| Children | IV co-amoxiclav or third-generation cephalosporin-based regimen according to weight and local policy | Cover streptococci and staphylococci; Hib coverage remains relevant in non-vaccinated or incompletely vaccinated populations. |
| Penicillin allergy | Clindamycin plus ciprofloxacin, or local guideline alternative | Useful tissue penetration; adjust after cultures. |
| Suspected mucormycosis | IV liposomal amphotericin B plus urgent surgical debridement | Do not delay surgery; control diabetes/DKA urgently. |
C. Adjunctive Measures
- Analgesics, antipyretics, fluids, and sepsis management where required.
- Nasal saline irrigation and topical nasal decongestants to improve sinus drainage.
- Steroids are controversial: they may reduce oedema in selected bacterial Chandler II-III cases after antibiotics have started, but must be avoided in suspected fungal infection.
D. Indications for Surgical Drainage
- Orbital abscess or significant subperiosteal abscess on imaging.
- No clinical improvement after 24-48 hours of adequate IV antibiotics.
- Visual compromise: reduced VA, RAPD, impaired colour vision, optic nerve compression, or worsening ophthalmoplegia.
- Large abscess, commonly >10 mm, or enlarging abscess on repeat imaging.
- Non-medial abscess, especially superior, lateral, inferior, or posterior collection.
- Age >9 years, because older children behave more like adults and are more likely to need drainage.
- Fungal infection, foreign body, dental source, or intracranial extension.
E. Surgical Approaches
| Approach | Indication | Key Points |
|---|---|---|
| Endoscopic sinus surgery / FESS | Medial subperiosteal abscess and sinus drainage | Combined ENT-ophthalmology approach; transnasal, minimal scarring; preferred for most medial abscesses. |
| External medial approach / Lynch incision / orbitonasal approach | Medial or superior abscess, failed FESS, large collection | Good access; may be combined with FESS. |
| Lateral orbitotomy | Lateral or posterior orbital abscess | Used when not accessible endoscopically. |
| Inferior orbitotomy / transconjunctival approach | Inferior subperiosteal abscess | Provides access with minimal visible scar. |
| Frontal sinus trephination | Frontal sinusitis with superior abscess or Pott's puffy tumour | Allows frontal sinus drainage with orbital drainage when required. |
Management Algorithm
- Suspected orbital cellulitis: admit, CT orbit/PNS with contrast, FBC, CRP, blood cultures, glucose, and full ophthalmic assessment.
- Chandler I-II without abscess: IV antibiotics, close monitoring every 6-8 hours, repeat CT in 24-48 hours if not improving.
- Chandler III subperiosteal abscess: small medial abscess in child <9 years without visual compromise may receive initial IV antibiotics and close review; age >9 years, non-medial abscess, >10 mm abscess, visual threat, or deterioration requires drainage.
- Chandler IV orbital abscess: urgent surgical drainage plus IV antibiotics.
- Chandler V cavernous sinus thrombosis: ICU, broad-spectrum IV antibiotics, LMWH anticoagulation, MRI/MRV, ENT/neurosurgery involvement.
Ocular Complications
- Visual loss from central retinal artery occlusion, central retinal vein occlusion, ischaemic optic neuropathy, or compressive optic neuropathy.
- Exposure keratopathy and corneal ulceration due to severe proptosis.
- Raised IOP and secondary glaucoma.
- Exudative retinal detachment.
- Panophthalmitis in severe delayed disease.
Intracranial Complications
- Cavernous sinus thrombosis: bilateral chemosis/proptosis, high septic fever, headache, meningism, altered sensorium, and ophthalmoplegia.
- Meningitis due to direct or haematogenous spread.
- Subdural empyema, extradural abscess, brain abscess, or frontal lobe abscess.
Systemic Complications
- Septicaemia and septic shock.
- Osteomyelitis of orbital walls or frontal bone.
- Pott's puffy tumour: frontal osteomyelitis with subperiosteal abscess.
Cavernous Sinus Thrombosis: Exam Table
| Feature | Cavernous Sinus Thrombosis |
|---|---|
| Earliest cranial nerve palsy | CN VI abducens palsy, because CN VI runs within the cavernous sinus lumen alongside the ICA; CN III, IV, V1, and V2 are in the lateral wall. |
| Hallmark | Bilateral chemosis and proptosis due to contralateral spread through intercavernous sinuses. |
| Symptoms | Severe headache, high swinging fever, photophobia, meningism, altered sensorium. |
| CT with contrast | Lateral convexity or bulging of the cavernous sinus, filling defects within the sinus, and engorgement of the superior ophthalmic vein. |
| MRI/MRV | Gold standard; shows loss of flow void in the cavernous sinus and venous filling defect on MR venography. |
| Management | Broad-spectrum IV antibiotics, LMWH anticoagulation, ICU support, ENT and neurosurgery involvement. |
Rhino-Orbital Mucormycosis
In diabetic ketoacidosis or immunocompromised patients, Mucorales such as Rhizopus, Mucor, and Absidia cause angioinvasive fungal infection. It is a separate emergency entity and should be suspected when orbital cellulitis is associated with necrosis, black eschar, rapid visual loss, or orbital apex involvement.
- Black eschar on nasal mucosa or palate is a key clue.
- Rapid orbital apex involvement may cause sudden blindness.
- Cavernous sinus involvement may occur early.
- Treatment is urgent control of diabetes/DKA, IV liposomal amphotericin B, aggressive surgical debridement of necrotic tissue, and possible orbital exenteration.
- Steroids must be avoided when fungal infection is suspected.
Paediatric Orbital Cellulitis
- Children <9 years with small medial subperiosteal abscess, no RAPD, normal vision, and good response to antibiotics may be managed medically with very close monitoring.
- Children >9 years behave more like adults and have a higher likelihood of polymicrobial infection and need for drainage.
- Empirical antibiotic choice should reflect local vaccination status; Hib is now uncommon in routinely Hib-vaccinated populations but remains a historical PYQ organism.
Trap 1 — TRUE
“The medial wall of the orbit is the most common site of subperiosteal abscess in orbital cellulitis.”
The medial wall, especially the lamina papyracea adjacent to the ethmoid sinus, is the commonest site. Do not choose the roof merely because frontal sinusitis can cause superior abscess.
Trap 2 — TRUE
“The first cranial nerve affected in cavernous sinus thrombosis is CN VI.”
CN VI runs within the cavernous sinus lumen alongside the ICA, while CN III, IV, V1, and V2 run in the lateral wall; abduction limitation is the classic early palsy.
Trap 3 — FALSE
“The degree of lid swelling alone distinguishes orbital cellulitis from preseptal cellulitis.”
The key differentiators are proptosis, painful restricted extraocular movements, chemosis, reduced VA/colour vision, RAPD, and postseptal changes on imaging.
Trap 4 — TRUE
“Bilateral proptosis, bilateral chemosis, septic fever, and meningism in orbital cellulitis suggest cavernous sinus thrombosis.”
These features indicate Chandler V disease and require ICU care, broad-spectrum IV antibiotics, MRI/MRV, LMWH anticoagulation, and neurosurgical/ENT input.
Trap 5 — FALSE
“The empty delta sign on CT is a sign of cavernous sinus thrombosis.”
The empty delta sign is classically a CT sign of superior sagittal sinus thrombosis. In cavernous sinus thrombosis, CT with contrast may show cavernous sinus bulging, filling defects, and superior ophthalmic vein engorgement; MRI/MRV is preferred.
Trap 6 — FALSE
“H. influenzae type b remains a dominant cause of paediatric orbital cellulitis in routinely Hib-vaccinated populations.”
Hib was historically important, but its incidence has declined sharply after Hib vaccination. In vaccinated populations, Staphylococcus aureus and streptococcal species are now more prominent; non-typeable H. influenzae can still occur.
Q: What is the investigation of choice in orbital cellulitis?
A: CT orbit and paranasal sinuses with contrast. It differentiates preseptal from postseptal infection, detects abscess, shows sinus disease and bony erosion, and guides surgical planning.
Q: When would you operate on a child with orbital cellulitis?
A: Operate for visual compromise, RAPD, worsening EOM/proptosis, no improvement after 24-48 h IV antibiotics, abscess >10 mm, non-medial abscess, age >9 years, or orbital abscess.
Q: A diabetic patient has orbital cellulitis, black nasal eschar, and rapid visual loss. Diagnosis and management?
A: Rhino-orbital mucormycosis. Urgently control DKA, start IV liposomal amphotericin B, perform aggressive surgical debridement with ENT/ophthalmology, and consider exenteration if required.
Q: What is the key clinical distinction between preseptal and orbital cellulitis?
A: Orbital cellulitis has postseptal signs: proptosis, painful restricted EOM, chemosis, possible reduced VA, RAPD, raised IOP, and systemic toxicity.
Q: Which cranial nerve is classically first affected in cavernous sinus thrombosis?
A: CN VI, because it runs within the cavernous sinus lumen; this causes early lateral rectus palsy and impaired abduction.
Q: What imaging findings suggest cavernous sinus thrombosis?
A: MRI/MRV shows loss of cavernous sinus flow void and venous filling defect. CT contrast may show cavernous sinus bulging, filling defects, and engorged superior ophthalmic vein.
A 7-year-old boy presents with 2 days of right-sided lid swelling, fever of 39.2°C, and restricted painful EOM. CT shows an 8 mm medial subperiosteal abscess adjacent to the right ethmoid sinus. VA is 6/6 and there is no RAPD. How would you manage him, and what are the criteria for stepping up to surgery?
Answer
This child is suitable for initial medical management under close observation because he is <9 years old, has a medial subperiosteal abscess <10 mm, has no RAPD, and has preserved vision. Management includes admission, IV broad-spectrum antibiotics such as weight-based co-amoxiclav with anaerobic cover according to local policy, ENT review, nasal decongestants or saline irrigation, analgesics, antipyretics, and frequent monitoring of VA, pupils, colour vision, EOM, proptosis, temperature, and CRP. Step up to surgery if VA worsens, RAPD develops, EOM restriction or proptosis increases, there is no improvement after 24-48 hours of IV antibiotics, the abscess enlarges beyond 10 mm or extends superiorly/laterally/posteriorly, or the child remains febrile and toxic. Surgical treatment would usually be combined ENT-ophthalmology endoscopic drainage with FESS/ethmoidectomy, pus culture, and continued IV antibiotics.
References
- Chandler JR, Langenbrunner DJ, Stevens ER. The pathogenesis of orbital complications in acute sinusitis. Laryngoscope. 1970;80(9):1414-1428.
- Harris GJ. Subperiosteal abscess of the orbit: age as a factor in the bacteriology and response to treatment. Ophthalmology. 1994;101(3):585-595.
- Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach. 8th ed. Elsevier; 2016.
- Yanoff M, Duker JS. Ophthalmology. 5th ed. Elsevier; 2019.
- American Academy of Ophthalmology. Basic and Clinical Science Course: Orbit, Eyelids and Lacrimal System. Section 7; 2023-2024.
- Barone SR et al. Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination. Pediatrics. 2000.
- Nageswaran S et al. Orbital cellulitis in children. Pediatr Infect Dis J. 2006;25(8):695-699.